Article Figures & Data
Figures
- Figure 1.
Activation of resident fibroblasts by stimuli associated with tissue injury.
- Figure 2.
Possible origin of matrix-producing cells in the kidney.
Tables
Cell Type Markers Specific Characteristics References Resident Fibroblasts FSP1, HSP47, 5′ectonucleotidase, CD44, ICAM, DDR2 Phenotypic variability between cortical and medullary fibroblasts 41, 44, 63 Myofibroblasts α-SMA 13 Pericytes α-SMA, NG2, PDGFR-2, Desmin Associated capillaries and venoles 64, 65 Vascular smooth muscle cells α-SMA, caldesmon, calponin Associated arteries, arterioles, veins 64 EMT-derived fibroblasts FSP1 (residual epithelial markers?) Exclusively found in fibrotic kidneys 41, 44 Mesenchymal stem cells FSP1? 44 ↵a At least 6 distinct cell types with mesenchymal phenotypes can be detected in the kidney. Due to the lack of specific markers, identification of the different lineages can be challenging. In the normal kidney, myofibroblasts can be distinguished from vascular smooth muscle cells and pericytes based on topographical criteria. Without genetic markers, indisputable identification of EMT-derived cells and mesenchymal stem cells is not feasible as of yet. HSP47, heat shock protein 47; ICAM, intracellular adhesion molecule; DDR2, discoidin domain receptor; α-SMA, α-smooth muscle actin; NG2, neuron glial antigen 2; PDGFR, PDGF receptor; EMT, epithelial–mesenchymal transition.
In this issue
Jump to section
More in this TOC Section
Cited By...
- Chronic Allograft Injury
- LncRNA GAS5 attenuates fibroblast activation through inhibiting Smad3 signaling
- The Ser/Thr kinase p90RSK promotes kidney fibrosis by modulating fibroblast-epithelial crosstalk
- Transforming growth factor {beta} (TGF{beta}) and related molecules in chronic kidney disease (CKD)
- The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
- An immunofluorescence assay for extracellular matrix components highlights the role of epithelial cells in producing a stable, fibrillar extracellular matrix
- Renal Mechanisms of Association between Fibroblast Growth Factor 1 and Blood Pressure
- Precision-cut kidney slices (PCKS) to study development of renal fibrosis and efficacy of drug targeting ex vivo
- Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice
- Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis
- Curtailing Endothelial TGF-{beta} Signaling Is Sufficient to Reduce Endothelial-Mesenchymal Transition and Fibrosis in CKD
- Role of the potassium channel KCa3.1 in diabetic nephropathy
- Mathematical model of renal interstitial fibrosis
- Role of 6-O-Sulfated Heparan Sulfate in Chronic Renal Fibrosis
- Potassium Channels, Renal Fibrosis, and Diabetes
- Disruption of the Dapper3 Gene Aggravates Ureteral Obstruction-mediated Renal Fibrosis by Amplifying Wnt/{beta}-catenin Signaling
- A2B Adenosine Receptor-Mediated Induction of IL-6 Promotes CKD
- Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
- TLR4 Promotes Fibrosis but Attenuates Tubular Damage in Progressive Renal Injury
- Identification of Epithelial to Mesenchymal Transition as a Novel Source of Fibroblasts in Intestinal Fibrosis
- Inhibition of Integrin-Linked Kinase Attenuates Renal Interstitial Fibrosis
- Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels
- Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
- tPA Protects Renal Interstitial Fibroblasts and Myofibroblasts from Apoptosis
- PINCH-1 Promotes Tubular Epithelial-to-Mesenchymal Transition by Interacting with Integrin-Linked Kinase